{
  "system": "hedgefund",
  "title": "Hedge Fund Edge Tracker",
  "updated_at": "2026-02-17T05:29:21.807363+00:00",
  "total_positions": 20,
  "active_count": 0,
  "publish_count": 0,
  "watch_count": 4,
  "killed_count": 12,
  "pending_count": 4,
  "total_pnl": 0,
  "win_rate": 0,
  "best_trade": 0,
  "worst_trade": 0,
  "short_count": 8,
  "long_count": 6,
  "recent_positions": [
    {
      "asset": "Nicox: regulatory approval",
      "ticker": "XBI",
      "direction": "LONG",
      "confidence": 55.0,
      "band": "B",
      "entry_price": null,
      "dd_approved_price": 122.86,
      "current_price": 122.86,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "WATCH",
      "headline": "Nicox pre-NDA feedback puts a date on the next catalyst - summer 2026 submission",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "DD approved \u2014 watching for signal confirmation",
      "conviction": 6,
      "thesis_status": "intact",
      "watching_for": "I will look for any new updates from Nicox regarding the NDA submission, confirm",
      "journal_count": 5,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "SGS: regulatory approval",
      "ticker": "SPY",
      "direction": "LONG",
      "confidence": 49.0,
      "band": "C",
      "entry_price": null,
      "dd_approved_price": 681.75,
      "current_price": 681.75,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "WATCH",
      "headline": "SGS 'approval' signal is contaminated by mismatch risk - bullish mechanism, but ",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "DD approved \u2014 watching for signal confirmation",
      "conviction": 5,
      "thesis_status": "weakening",
      "watching_for": "Next cycle, I am looking for official documents from regulatory bodies confirmin",
      "journal_count": 5,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "drug seizure and trafficking (pharmaceuticals)",
      "ticker": "IHE",
      "direction": "FADE",
      "confidence": 44.0,
      "band": "D",
      "entry_price": null,
      "dd_approved_price": 90.42,
      "current_price": 90.42,
      "current_pnl": null,
      "report_pnl": 0,
      "state": "WATCH",
      "headline": "Counterfeit and seizure narratives are everywhere - the signal is real, but it i",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "DD approved \u2014 watching for signal confirmation",
      "conviction": 6,
      "thesis_status": "intact",
      "watching_for": "I'm looking for a coherent enforcement action or clearer narratives that focus o",
      "journal_count": 3,
      "signal_velocity": "stirring",
      "signal_hits_24h": 1
    },
    {
      "asset": "ICICI Securities: growth and margin improvement",
      "ticker": "ICICISEC.NS",
      "direction": "FADE",
      "confidence": 37.0,
      "band": "D",
      "entry_price": null,
      "dd_approved_price": 0.0,
      "current_price": null,
      "current_pnl": null,
      "report_pnl": null,
      "state": "WATCH",
      "headline": "",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "DD approved \u2014 watching for signal confirmation",
      "conviction": null,
      "thesis_status": null,
      "watching_for": "",
      "journal_count": 0,
      "signal_velocity": "stirring",
      "signal_hits_24h": 1
    },
    {
      "asset": "SGS: regulatory approval",
      "ticker": "SGSOY",
      "direction": "LONG",
      "confidence": 55.0,
      "band": "B",
      "entry_price": null,
      "dd_approved_price": null,
      "current_price": 12.25,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "PENDING",
      "headline": "SGS Says Belgium Cleared Its Radiolabelled ADME Unit Again - Small Operational G",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "Awaiting due diligence",
      "conviction": null,
      "thesis_status": null,
      "watching_for": "",
      "journal_count": 0,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "Bernstein Liebhard LLP: legal action",
      "ticker": "ORGN",
      "direction": "SHORT",
      "confidence": 54.0,
      "band": "C",
      "entry_price": null,
      "dd_approved_price": null,
      "current_price": 0.1537,
      "current_pnl": null,
      "report_pnl": -2.47,
      "state": "PENDING",
      "headline": "Origin Materials' Class Action Moves Into Settlement Mechanics - A Quiet Headlin",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "Awaiting due diligence",
      "conviction": null,
      "thesis_status": null,
      "watching_for": "",
      "journal_count": 0,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "Nicox: regulatory approval",
      "ticker": "COX",
      "direction": "LONG",
      "confidence": 54.0,
      "band": "C",
      "entry_price": null,
      "dd_approved_price": null,
      "current_price": null,
      "current_pnl": null,
      "report_pnl": null,
      "state": "PENDING",
      "headline": "Nicox Says the FDA Pre-NDA Readout Was Positive - The De-Risking Is Real, But th",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "Awaiting due diligence",
      "conviction": null,
      "thesis_status": null,
      "watching_for": "",
      "journal_count": 0,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "Dr. Lonser: regulatory development",
      "ticker": "SLDB",
      "direction": "LONG",
      "confidence": 46.0,
      "band": "C",
      "entry_price": null,
      "dd_approved_price": null,
      "current_price": 6.19,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "PENDING",
      "headline": "Solid Biosciences' FDA-Path Narrative Is Back in Circulation - High Optionality,",
      "publish_headline": "",
      "kill_reason": "",
      "state_reason": "Awaiting due diligence",
      "conviction": null,
      "thesis_status": null,
      "watching_for": "",
      "journal_count": 0,
      "signal_velocity": "quiet",
      "signal_hits_24h": 0
    },
    {
      "asset": "12 Panel Now: regulation",
      "ticker": "XBI",
      "direction": "SHORT",
      "confidence": 61.0,
      "band": "B",
      "entry_price": null,
      "dd_approved_price": 122.86,
      "current_price": 122.86,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "KILLED",
      "headline": "Drug-testing 'rule change' story looks like vendor marketing - the asymmetric ed",
      "publish_headline": "",
      "kill_reason": "KILL: The original thesis focused on a potentially non-exist",
      "state_reason": "KILL (watching): The original thesis focused on a potentiall",
      "conviction": 2,
      "thesis_status": "invalidated",
      "watching_for": "In this case, there is nothing left to watch for, as the signal has propagated w",
      "journal_count": 1,
      "signal_velocity": "mainstream",
      "signal_hits_24h": 6
    },
    {
      "asset": "William Panzera: drug trafficking and cryptocurren",
      "ticker": "SPY",
      "direction": "SHORT",
      "confidence": 59.0,
      "band": "B",
      "entry_price": null,
      "dd_approved_price": 681.75,
      "current_price": 681.75,
      "current_pnl": null,
      "report_pnl": 0.0,
      "state": "KILLED",
      "headline": "DOJ fentanyl case is real, but the tradeable read-through is second-order: compl",
      "publish_headline": "",
      "kill_reason": "KILL: The mechanism surrounding the DOJ fentanyl case and it",
      "state_reason": "KILL (watching): The mechanism surrounding the DOJ fentanyl ",
      "conviction": 3,
      "thesis_status": "invalidated",
      "watching_for": "I will keep an eye on any concrete policy actions or new guidance from the DOJ, ",
      "journal_count": 2,
      "signal_velocity": "mainstream",
      "signal_hits_24h": 50
    }
  ],
  "report_url": "https://ivanmassow.github.io/hedgefund-tracker/"
}